Skip to main content
Premium Trial:

Request an Annual Quote

Affy Licenses Genisphere's MiRNA Reagents

NEW YORK (GenomeWeb News) – Affymetrix plans to offer Genisphere's miRNA reagents for use with its GeneChip miRNA 2.0 Arrays under a new license agreement, Affy said today.

The company said it expects to launch integrated reagent kits that include Genisphere's FlashTag Biotin HSR Reagents under the Affymetrix brand in early 2012.

Genisphere's reagents are compatible across a range of sample types, including formalin-fixed, paraffin-embedded fresh frozen samples and blood, for use in studies of the role of miRNAs in biological processes such as mRNA degradation, transcriptional gene silencing, translational repression, and biomarker discovery projects for translational and cancer research.

"This reagent addition provides researchers with the tools to move from a whole-genome view of complex biological systems using the GeneChip miRNA Arrays to single-gene validation with QuantiGene View miRNA Assays," Kevin Cannon, general manager of Affy's Gene Expression business unit, said in a statement.

Affy and Genisphere announced on Wednesday an agreement to exclusively license Genisphere's RNA amplification and labeling technology for use in FFPE samples.

Financial terms of the license agreement were not released.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.